硝基胍的毒性研究

目的对硝基胍的毒性进行研究,为制订卫生标准提供依据.方法包括急性毒性试验、蓄积毒性试验及亚慢性毒性试验.结果硝基胍大鼠经口LD50为8 066 mg/kg,小鼠经口LD50为10 044 mg/kg,蓄积系数大于5.3.亚慢性毒性试验中,高剂量组雄性大鼠在染毒第3周和第8周,体重有明显的负增长(P＜0.05);高剂量组雄性大鼠睾丸脏器系数明显高于对照组(P＜0.05);红细胞免疫功能测定结果显示,中、高剂量组大鼠红细胞受体花环率分别为10.00±2.37和7.50±2.66,明显低于对照组(P＜0.05,P＜0.01).其余各项指标未见明显改变.结论硝基胍属于微毒级毒物,轻度蓄积,亚慢性毒性试验对动物有一定的影响.     

1996-2000年某医院五种恶性肿瘤例均住院费用分析

恶性肿瘤是给群众带来严重健康损害的经济负担的疾病之一,已经列居我国城市 疾病死亡原因的第一位。本研究利用医院为基础的五种恶性肿瘤住院患者的费用数据,分析1996-2000年五种恶性肿瘤患者例均住院费用的变化趋势,比较自费患者和公费患者之间的例均费用差异。根据恶性肿瘤费用水平高、增长幅度快,且公费患者费用明显高于自费患者的情况,提出在医疗保障制度改革的社会环境下,医院必须加强病种费用管理,主动控制医疗费用水平。     

TBS诊断系统在宫颈病变中的应用研究

目的：对642例查体病人的宫颈涂片进行分析，研究宫颈良性病变和癌前病变及癌变在正常人群中的的发病率。方法：应用TBS系统对兰州市某大型商场30～51岁妇女642例行子宫颈涂片，显微镜下阅片，作出诊断，并对SIL以上的病例行阴道镜下活检术，进行病理检查。结果：正常582例，异常60剜，全部病例中仅1例漏诊。结论：TBS诊断系统与病理和临床诊断趋于一致，具有很高的准确性和适用性。     

整合素β1在自身免疫性心肌炎小鼠心肌的表达

目的:观察整合素β1在自身免疫性心肌炎小鼠心肌的表达变化。方法:猪肌凝蛋白皮下注射免疫Balb/c小鼠,建立慢性自身免疫性心肌炎模型,于初次免疫后14、30和60d对心肌组织进行病理学检查,同时用激光共聚焦技术和间接免疫荧光法检测整合素β1在心肌的表达变化。结果:在初次免疫后14d,小鼠心脏有局部炎症出现,整合素β1在心脏血管周围的表达高于正常组（P<0.05）;在第30天,小鼠心脏炎性浸润更加明显,整合素β1在心肌的表达增强,显著高于正常组（P<0.05）;第60天,小鼠心脏炎症细胞减少,而纤维化则开始出现,整合素β1在心肌的表达最强（P<0.05）,且排列紊乱。结论:整合素β1在自身免疫性心肌炎的发生及发展过程中起着不同重要作用,整合素β可能参与自身免疫反应及心肌的重构。     

肝VX-2 瘤模型MR扩散成像的实验研究

目的探讨肝VX-2瘤模型MR扩散成像特征.方法新西兰大白兔35只,采用块种植的方法,一期预实验皮下种植14只,肝内种植6只;二期肝内种植12只,另3只做正常对照.对包括二期肝内种植在内的15个肿瘤于种植前后行定期扩散加权成像(DWI) 与MR检查.以表观扩散系数(ADC)值等为指标进行统计分析.结果 (1)一期预实验,皮下种植成功率29%(4/14),肝内种植成功率33%(2/6);二期肝内种植成功率83%(10/12).(2)VX-2瘤在DWI上呈高信号,边缘清楚.正常组与VX-2瘤实验组b值为100和300 s/mm2时ADC值分别为(2.57±0.26)mm2/s、(1.73±0.31)mm2/s、(1.87±0.25)mm2/s与(1.57±0.23)mm2/s(F=43.26,P<0.001).随b值增大,病灶信号降低;ADC图上病灶呈低信号;不同b值之间病灶ADC值差异有统计学意义(P<0.05);b=100 s/mm2病灶与正常肝脏之间ADC值差异有统计学意义(P<0.01).(3)VX-2瘤发展迅速,易发生肺、肝、纵隔等处转移.结论 DWI在反映肝VX-2瘤内部水分子运动、发现与追踪病灶进展等方面有重要价值.     

食管钡餐连续摄影用于诊断早期食管癌的初步临床应用

目的 :介绍食管钡餐连续摄影用于诊断早期食管癌的初步临床应用。方法 :用德国产的数字化胃肠机检查并诊断了 6例早期食管癌病人。与常规食管双重对比造影类似 ,病人立位口服钡剂 ,同时进行连续摄影 ,速度为 2帧 s,持续约 10s。观察不同的时相 ,包括充盈相、黏膜相和双对比相。结果 :在 6例病人中可见食管功能的改变及黏膜皱襞的病变 ,用连续摄影诊断后经内镜及病理检查确诊。 4例病人有轻度扩张受限 ,2例病人有痉挛性收缩 ,1例有钡剂滞留。 6例病人中均可见增粗的或中断的黏膜。 5例病人可见小溃疡。结论 :食管钡餐连续摄影可提供更全面的信息。用此法更可提供食管功能性的改变。     

Isolation and characterization of marine luminous bacteria from shallow coastal waters of Taiwan.

BACKGROUND AND PURPOSE: Marine luminous bacteria were isolated and identified from samples in shallow coastal waters of Taiwan during the relatively warm seasons. METHODS: Identification of the luminous isolates was performed based on differences of phenotypic and genotypic characteristics together with data from phylogenetic analysis. RESULTS: Twenty seven strains of marine luminous bacteria were isolated. They were divided into five types based on differences of phenotypic characteristics. However, they could be clustered into only two genotypes according to the analysis of restriction patterns of polymerase chain reaction-amplified 16S rRNA genes digested with various restriction enzymes. The characterization data together with the 16S rRNA gene-based phylogenetic analysis revealed that the isolates included in phenotype I (seven isolates) could be Photobacterium leiognathi, and those included in phenotypes II-V (twenty isolates) might be classified as Vibrio harveyi. However, phylogeny based on gyrB sequences indicated that phenotypes II-V could be classified into two species, V. harveyi and Vibrio campbellii. CONCLUSION: Culturable luminous bacteria in the shallow coastal waters of Taiwan during the sampling period are dominated by V. harveyi/campbellii and P. leiognathi, and the former species appeared to be more prevalent and numerous than the latter species in general.     

MHC—I类抗原加工途径异常与肿瘤关系的研究进展

随着免疫学研究的不断深入，MHC－I类抗原呈递细节已逐渐明晰，全面认识肿瘤细胞MHC－I类相关抗原加工途径缺陷或改变与肿瘤生物学及肿瘤临床的关系，将有助于肿瘤的诊治和预防。     

弥漫性大B细胞淋巴瘤的病理、免疫组化特征及IgH基因重排的检测

目的 探讨弥漫性大B细胞淋巴瘤(DLBCL)临床和病理组织学特征以及免疫组化特异性抗体及IgH基因重排检测在其诊断和鉴别诊断中的价值。方法 收集30例弥漫性大B细胞淋巴瘤及其临床资料，用免疫组化孓P法标记LCA，CD20，CD79a，CD30及bcl-2抗体和用PCR方法检测15例IgH基因重排。结果 70％(21／30)弥漫性大B细胞淋巴瘤发病年龄在40～70岁，淋巴结内外都可累及。组织病理学：中心母细胞淋巴瘤占83．3％(25／30)，免疫母细胞淋巴瘤占3．3％(1／30)，间变性大细胞淋巴瘤占6．7％(2／30)，及富于T细胞B细胞淋巴瘤占6．7％(2／30)。免疫标记LCA均表现阳性，CD20、CD79a、CD30、bcl-2表达率分别为86．7％(26／30)，93．3％(28／30)，6．7％(2／30)，20％(6／30)。15例DLBCL中IgH基因重排阳性为66．7％(10／15)。结论 弥漫性大B细胞淋巴瘤是一组异质性肿瘤，必须结合其组织病理学形态和特异抗体的免疫组化检测，对一些疑难病例需做IgH基因重排检测以进行诊断和鉴别诊断。     

Effects of chimeric molecule of recombinant Dsg3EC1-2 with toxin PE40 on T and B lymphocytes in Pemphigus Vulgaris

Objective:To observe the effects of the recombinant chimeric toxin Dsg3EC1-2PE40 on T and B lymphocytes isolated from Pemphigus Vulgaris (PV) patients to further study its biological therapeutic function for PV. Methods :Recombinant chimeric toxin Dsg3EC1-2PE40 was first identified, expressed and purified, and then its effects on T and B lymphocytes of PV patients in vitro were detected and quantified by ELISPOT assay and MTT assay. Results :The purity of the expressed protein Dsg3EC1-2PE40 was up to 80%. In ELISPOT assay, with Dsg3EC1-2PE40, the overall number of B cells that produce anti-Dsg3 antibodies among PV patients was only about 60% of the comparable number with Dsg3EC1-2. The proliferation of T cells of PV patients was inhibited markedly by Dsg3EC1-2PE40. There was significant difference between the different groups with Dsg3EC1-2PE40 and Dsg3EC1-2. Conclusion:The recombinant chimeric toxin Dsg3EC1-2PE40 decrease the number of B cells that produce anti-Dsg3 antibodies in PV patients and can inhibit or kill T cells of PV patients in vitro.